glo1 semaglutide Shows Secondary Cardiovascular Prevention Benefits in Patients Without Diabetes GLP-1 Weight Loss Medication -

The committee is recommending that Novo Nordisk update the product label for drugs containing semaglutide to include non-arteritic anterior ischemic optic neuropathy as a side effect with a frequency of "very rare." In recent weeks, Novo Nordisk has seen its stock price tumble to multiyear lows, following a July 29 announcement that the Danish drugmaker was slashing its sales and profit projections for 2025

B., & Ahn, K

What is changing, and why Oestrogen is one of the body's most powerful anti-inflammatory hormones

The therapeutic potential of cyanidin-3-O-glucoside relating to female reproductive health

Your provider can opt-out of automatic refills if needed

It is known for its role in modulating melanin production, which can influence skin tone.